Rockefeller Capital Management L.P. - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$17
+41.7%
40,0000.0%0.00%
Q4 2022$12
-99.9%
40,0000.0%0.00%
Q3 2022$23,000
-25.8%
40,0000.0%0.00%
Q2 2022$31,000
-26.2%
40,0000.0%0.00%
Q1 2022$42,000
+16.7%
40,0000.0%0.00%
Q4 2021$36,000
-55.0%
40,0000.0%0.00%
Q3 2021$80,000
-7.0%
40,0000.0%0.00%
Q2 2021$86,000
-4.4%
40,0000.0%0.00%
-100.0%
Q1 2021$90,000
+157.1%
40,000
+100.0%
0.00%
Q4 2020$35,000
-18.6%
20,0000.0%0.00%
Q3 2020$43,00020,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2022
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$9,1000.00%
D.B. Root & Company, LLC 12,050$5,4830.00%
SeaCrest Wealth Management, LLC 37,063$16,8640.00%
SNS Financial Group, LLC 10,000$4,5500.00%
Virtu Financial LLC 29,061$130.00%
VisionPoint Advisory Group, LLC 3,142$1,4300.00%
Community Bank, N.A. 13,226$5,9510.00%
Verition Fund Management LLC 148,000$67,3400.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$49,5500.00%
Traynor Capital Management, Inc. 11,777$5,3590.00%
View complete list of AIM IMMUNOTECH INC shareholders